Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetrotide start day comparison in women with polycystic ovaries undergoing IVF/ICSI
2007-007932-25Phase 3Completed
- Sponsor
- Merck Santé
- Start
- Feb 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cetrorelix in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Merck Santé. Primary endpoint: Estradiol level on releasing day. Started Feb 2008; status: completed.
02
Drugs
cetrorelix
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2007-007932-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007932-25.